221 related articles for article (PubMed ID: 33509226)
1. The miR-1185-2-3p-GOLPH3L pathway promotes glucose metabolism in breast cancer by stabilizing p53-induced SERPINE1.
Xu Y; Chen W; Liang J; Zeng X; Ji K; Zhou J; Liao S; Wu J; Xing K; He Z; Yang Y; Liu Q; Zhu P; Liu Y; Li L; Liu M; Chen W; Huang W
J Exp Clin Cancer Res; 2021 Jan; 40(1):47. PubMed ID: 33509226
[TBL] [Abstract][Full Text] [Related]
2. The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.
He S; Niu G; Shang J; Deng Y; Wan Z; Zhang C; You Z; Shen H
J Exp Clin Cancer Res; 2017 Oct; 36(1):137. PubMed ID: 28978336
[TBL] [Abstract][Full Text] [Related]
3. MircoRNA-1275 promotes proliferation, invasion and migration of glioma cells via SERPINE1.
Wu DM; Wang S; Wen X; Han XR; Wang YJ; Fan SH; Zhang ZF; Shan Q; Lu J; Zheng YL
J Cell Mol Med; 2018 Oct; 22(10):4963-4974. PubMed ID: 30024092
[TBL] [Abstract][Full Text] [Related]
4. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-361-3p promotes human breast cancer cell viability by inhibiting the E2F1/P73 signalling pathway.
Hua B; Li Y; Yang X; Niu X; Zhao Y; Zhu X
Biomed Pharmacother; 2020 May; 125():109994. PubMed ID: 32092817
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting.
Li P; Xu T; Zhou X; Liao L; Pang G; Luo W; Han L; Zhang J; Luo X; Xie X; Zhu K
Cancer Med; 2017 Mar; 6(3):662-672. PubMed ID: 28220627
[TBL] [Abstract][Full Text] [Related]
7. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.
Deng R; Huang JH; Wang Y; Zhou LH; Wang ZF; Hu BX; Chen YH; Yang D; Mai J; Li ZL; Zhang HL; Huang Y; Peng XD; Feng GK; Zhu XF; Tang J
Mol Cancer; 2020 Aug; 19(1):122. PubMed ID: 32771023
[TBL] [Abstract][Full Text] [Related]
8. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
Xiao B; Chen D; Zhou Q; Hang J; Zhang W; Kuang Z; Sun Z; Li L
BMC Cancer; 2019 Sep; 19(1):891. PubMed ID: 31492116
[TBL] [Abstract][Full Text] [Related]
9. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis.
Liu X; Yao W; Xiong H; Li Q; Li Y
Cancer Biomark; 2020; 29(2):277-290. PubMed ID: 32675392
[TBL] [Abstract][Full Text] [Related]
10. MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.
Xue J; Chi Y; Chen Y; Huang S; Ye X; Niu J; Wang W; Pfeffer LM; Shao ZM; Wu ZH; Wu J
Oncogene; 2016 Jan; 35(4):448-58. PubMed ID: 25867061
[TBL] [Abstract][Full Text] [Related]
11. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway.
Zhang M; Wang Y; Jiang L; Song X; Zheng A; Gao H; Wei M; Zhao L
J Exp Clin Cancer Res; 2021 Jan; 40(1):41. PubMed ID: 33494806
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
[TBL] [Abstract][Full Text] [Related]
13. A miRNA-HERC4 pathway promotes breast tumorigenesis by inactivating tumor suppressor LATS1.
Xu Y; Ji K; Wu M; Hao B; Yao KT; Xu Y
Protein Cell; 2019 Aug; 10(8):595-605. PubMed ID: 30710319
[TBL] [Abstract][Full Text] [Related]
14. The long noncoding RNA MIR210HG promotes tumor metastasis by acting as a ceRNA of miR-1226-3p to regulate mucin-1c expression in invasive breast cancer.
Li XY; Zhou LY; Luo H; Zhu Q; Zuo L; Liu GY; Feng C; Zhao JY; Zhang YY; Li X
Aging (Albany NY); 2019 Aug; 11(15):5646-5665. PubMed ID: 31399552
[TBL] [Abstract][Full Text] [Related]
15. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-590-3P suppresses cell survival and triggers breast cancer cell apoptosis via targeting sirtuin-1 and deacetylation of p53.
Abdolvahabi Z; Nourbakhsh M; Hosseinkhani S; Hesari Z; Alipour M; Jafarzadeh M; Ghorbanhosseini SS; Seiri P; Yousefi Z; Yarahmadi S; Golpour P
J Cell Biochem; 2019 Jun; 120(6):9356-9368. PubMed ID: 30520099
[TBL] [Abstract][Full Text] [Related]
18. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
Qiao K; Ning S; Wan L; Wu H; Wang Q; Zhang X; Xu S; Pang D
J Exp Clin Cancer Res; 2019 Oct; 38(1):418. PubMed ID: 31623640
[TBL] [Abstract][Full Text] [Related]
19. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
20. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]